Key takeaways:
Ambien (zolpidem) and Sonata (zaleplon) are sedative medications that are approved to treat sleeping problems (insomnia). They’re commonly referred to as “Z-drugs,” and they work in the same way to cause drowsiness.
Sonata doesn’t last as long in the body as Ambien does. It also starts working more quickly and may have fewer medication interactions.
Experts agree that cognitive behavioral therapy (CBT) is the first-choice treatment for ongoing insomnia. Neither Ambien nor Sonata is recommended as a long-term treatment for sleep issues.
Ambien (zolpidem) and Sonata (zaleplon) are sedative medications that are used to help people sleep. They belong to the same class of medications, which is commonly referred to as “Z-drugs.”
Here, we’ll cover nine things you need to know about Ambien and Sonata.
Just keep in mind that Sonata is now only available as the generic version, zaleplon, in the U.S. But many people still refer to zaleplon as Sonata, because it's easier to say. Because of this, we’ll refer to zaleplon as Sonata throughout this piece.
Ambien and Sonata are commonly known as Z-drugs. They’re part of a group of medications called GABA agonists. GABA is a chemical in the body that has many functions, including having a calming effect on the brain.
Ambien and Sonata work by activating certain areas in your brain called GABA-A receptors. By activating these receptors, they help slow your brain down, which makes you sleepy.
Ambien and Sonata have many similarities, which we discuss throughout this article. But they also have some differences.
Both Ambien and Sonata are FDA-approved to treat insomnia. The American Academy of Sleep Medicine (AASM) considers both prescription medications for sleep to be only minimally effective — but also minimally harmful with short-term use.
These medications are recommended for slightly different uses:
Sonata can be taken at bedtime to help you fall asleep.
Ambien can be taken at bedtime to help you fall asleep and stay asleep.
There’s also a version of zolpidem (Intermezzo) that can be taken in the middle of the night to help you get back to sleep.
Sonata only comes as an immediate-release capsule. But zolpidem comes in three different forms:
Ambien
Zolpidem extended release (Ambien CR)
Sublingual zolpidem (Edluar, Intermezzo)
If you have trouble staying asleep, versus trouble falling asleep, Ambien CR might be a more effective option for you.
But people taking Ambien CR are more likely to experience certain side effects. These include next-day drowsiness and impaired ability to do activities that require alertness. In fact, the FDA issued a warning about this in 2013.
People taking Ambien CR may also be more likely to have side effects like hallucinations, nausea, and dizziness.
Sonata is the shortest-acting Z-drug. It works quickly, but it leaves the body quickly, too. This is why Sonata can be taken when you’re having trouble falling asleep, even after you’ve gone to bed. But Ambien should only be taken before bedtime and if you plan to sleep for at least 7 hours. If you get less than 7 hours of sleep after taking Ambien, you may wake up feeling drowsy or “hungover.”
Ambien is partially metabolized (broken down) by a major enzyme (protein) in the liver. Sonata is not as affected by this enzyme, so it’s less likely to have significant interactions.
Still, both medications have the potential to interact with other medications and substances. So don’t take Sonata or Ambien without asking your healthcare provider or pharmacist to check your medication list for interactions.
There’s some evidence that Sonata is less likely to be misused than Ambien and other Z-drugs. But this may also be because zaleplon is not as commonly prescribed as zolpidem, so there’s less information about its potential for misuse.
The AASM considers Ambien and Sonata reasonable options for treating some aspects of chronic insomnia in adults. But the organization’s guidelines also state that these medications should only be recommended as long-term treatments for people who don’t see positive effects from (or don’t have access to) cognitive behavioral therapy (CBT).
CBT for insomnia is a type of therapy that may help people change behaviors or feelings that keep them from sleeping well. It’s considered the first-choice treatment option for managing insomnia.
Long-term treatment with Ambien or Sonata isn’t recommended because of the risks associated with Z-drugs. These risks include trying to do activities that can be dangerous while sleeping, such as driving. They also have a risk for dependence and misuse, especially if not taken as prescribed. As mentioned above, some Z-drugs can also reduce your ability to perform activities that require alertness (like driving) the following day.
Ambien and Sonata are classified as controlled substances. This means they’re more likely to cause dependence and misuse than non-controlled medications. And there are restrictions on how they can be prescribed and refilled.
You should only take Ambien and Sonata as prescribed. When a person doesn’t follow a prescriber’s directions or takes medication they’re not prescribed, it can lead to a sedative use disorder. This is a medical condition in which a person has trouble controlling how much sedative substances they take.
Warning signs of sedative use disorder associated with Ambien and Sonata include:
Experiencing cravings for these medications
Continuing to take the medications even when it’s apparent their causing harm to the person’s personal or work life
Giving up activities or responsibilities
Physical dependence, which can present as tolerance and/or withdrawal symptoms
Tolerance is the need to take higher doses of a medication, like Ambien or Sonata, to get the same effect that you used to get with lower doses. Withdrawal is when you have physical or psychological symptoms after you stop taking, reduce the dose of, or are in between a dose of a medication, like a sedative. These symptoms may include stomach and muscle cramps, sweating, and shakiness. More serious symptoms, like seizures and confusion, can also occur.
Taking Ambien or Sonata exactly as prescribed and for the shortest amount of time possible can help prevent sedative use disorder. If you or someone you know struggles with substance misuse, help is available. Call SAMHSA’s National Helpline at 1-800-662-4357 to learn about resources in your area.
Like Z-drugs, benzodiazepines (“benzos”) work by activating GABA-A receptors. But benzos bind to more areas on the GABA-A receptor than Z-drugs. This may be why benzos are prescribed to help with anxiety but Z-drugs aren’t.
Benzos and Z-drugs are both controlled substances. But the following risks may be more likely with benzos:
Daytime drowsiness
Confusion, trouble focusing, or memory problems
A greater risk of dependence and misuse
Although benzos are thought to carry a higher risk of dependence and misuse, some research shows that this risk is more significant with Z-drugs than originally thought. Z-drugs are also more likely to cause abnormal sleep behaviors than benzos. This includes behaviors like sleep walking and driving while sleeping.
Combining Z-drugs with other medications that slow down the brain can be dangerous. In severe situations, this can lead to an overdose.
Medications and substances that should not be taken in combination with Z-drugs include:
Benzodiazepines like alprazolam (Xanax) and lorazepam (Ativan)
Opioids like hydrocodone/acetaminophen and tramadol (ConZip, Qdolo)
Barbiturates like phenobarbital
Tricyclic antidepressants like amitriptyline
Research shows that people taking an opioid in combination with a sedative are more likely to have an overdose than people taking an opioid alone. An overdose can be fatal and requires immediate medical attention.
In a large review that included almost 50 studies looking at Z-drugs for sleep, the results showed that Z-drugs shortened the time it took people to fall asleep, but only by about 13 minutes. So while Z-drugs may help you sleep, they may not have as significant of an effect as you hope. And the risks might outweigh the benefits.
Another study looked at over 150 people receiving Ambien 10 mg in combination with CBT or CBT alone for chronic insomnia. The study found that taking Ambien during the first 6 weeks of CBT did improve sleep. But those who continued on Ambien past the initial 6 weeks didn’t have better sleep than those who continued on CBT alone. This shows that long-term use of Ambien may not be as beneficial as CBT alone for insomnia.
Keep in mind: A 10 mg dose of Ambien may be higher than what’s appropriate for many people. Data has shown that taking Ambien 10 mg may lead to high levels of zolpidem in the blood for certain groups of people. This can result in an impaired ability to do activities the following morning.
The American Geriatrics Society (AGS) has a list of medications that are considered risky for older adults. Z-drugs are included on this list and should ideally be avoided by older adults. This is due to the risk of confusion, delirium, and falls with these medications.
Ambien and Sonata are sedative medications that are approved to treat chronic insomnia. They’re commonly referred to as “Z-drugs” and they work by calming your brain and causing drowsiness.
While many people tolerate Ambien and Sonata well, these medications carry significant risks, including abnormal sleep behaviors like sleep walking and driving while asleep. They can also lead to physical dependence or misuse, especially when not taken how they’re prescribed.
Neither Ambien nor Sonata is recommended as a long-term treatment option for sleep problems. Cognitive behavioral therapy (CBT) is considered the first-choice treatment option for insomnia.
Agravat, A. (2018). ‘Z’-hypnotics versus benzodiazepines for the treatment of insomnia. Progress in Neurology and Psychiatry.
American Academy of Sleep Medicine. (2020). Cognitive behavioral therapy.
A-S Medication Solutions. (2022). Zolpidem tartrate [package insert].
Beaulieu-Bonneau, S., et al. (2017). Long-term maintenance of therapeutic gains associated with cognitive-behavioral therapy for insomnia delivered alone or combined with zolpidem. Sleep.
Buscemi, N., et al. (2007). The efficacy and safety of drug treatments for chronic insomnia in adults: A meta-analysis of RCTs. Journal of General Internal Medicine.
DailyMed. (2019). Zolpidem tartrate sublingual [label].
DailyMed. (2022). Zolpidem tartrate extended-release [label].
Gunja, N. (2013). The clinical and forensic toxicology of Z-drugs. Journal of Medical Toxicology.
Jewett, B. E., et al. (2022). Physiology, GABA. StatPearls.
Kripke, D. F., et al. (2016). Hypnotic drug risks of mortality, infection, depression, and cancer: But lack of benefit. F1000 Research.
Monti, J. M., et al. (2009). Pharmacotherapy of insomnia: Focus on zolpidem extended release. Clinical Medicine Insights: Therapeutics.
Preferred Pharmaceuticals Inc. (2022). Zaleplon [package insert].
Sateia, M. J., et al. (2017). Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine.
Schifano, F., et al. (2019). An insight into Z-drug abuse and dependence: An examination of reports to the European Medicines Agency database of suspected adverse drug reactions. International Journal of Neuropsychopharmacology.
U.S. Food and Drug Administration. (2013). FDA drug safety communication: FDA approves new label changes and dosing for zolpidem products and a recommendation to avoid driving the day after using ambien CR.
U.S. Food and Drug Administration. (2018). Questions and Answers: Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist).
U.S. Food and Drug Administration. (2022). FDA adds boxed warning for risk of serious injuries caused by sleepwalking with certain prescription insomnia medicines.